Our study indicated that a high CHI3L1 expression was an independent prognostic factor for EOC, even in the patients whose residual tumor size < 1cm after debulking surgery or who receiving paclitaxel-platinum chemotherapy. The gene discussed is CHI3L1; the disease is neoplasm.